Daniella Mehalik
Director of Finance/CFO at PSYCHEMEDICS CORPORATION
Profile
Daniella Mehalik is currently the Vice President-Finance & Treasurer at Psychemedics Corp.
Prior to this, she worked as a Controller at NeuBase Therapeutics, Inc. from 2021 to 2023 and at DxTx Medical, Inc. from 2019 to 2021.
She holds undergraduate and graduate degrees from Carlow University Of.
Daniella Mehalik active positions
Companies | Position | Start |
---|---|---|
PSYCHEMEDICS CORPORATION | Director of Finance/CFO | 2023-11-26 |
Former positions of Daniella Mehalik
Companies | Position | End |
---|---|---|
NEUBASE THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 2022-12-31 |
DxTx Medical, Inc. | Comptroller/Controller/Auditor | 2020-12-31 |
Training of Daniella Mehalik
Carlow University Of | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
PSYCHEMEDICS CORPORATION | Health Services |
Private companies | 2 |
---|---|
NeuBase Therapeutics, Inc.
NeuBase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology NeuBase Therapeutics, Inc. is a biotechnology company, which engages in the development of drugs for patients with genetic neurological disorders. The firm’s therapies are built on a proprietary platform called PATrOL that encompasses a novel peptide-nucleic acid antisense oligonucleotide technology combined with novel delivery shuttles that overcome many of the hurdles to selective mutation engagement, repeat dosing, and systemic delivery of genetic medicines. The company was founded by Dietrich A. Stephan on August 4, 2009 and is headquartered in Pittsburgh, PA. | Health Technology |
DxTx Medical, Inc. |
- Stock Market
- Insiders
- Daniella Mehalik